IVETTE CARDENAS-ESPRIT: Open Payments
NPI 1124878202 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $366 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Recor Medical Inc | 1 | $149 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Vifor Pharma, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Ardelyx, Inc. | 2 | $56 |
| Travere Therapeutics, Inc. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
Products named: Paradise Ultrasound Renal Denervation System, JYNARQUE, Veltassa, IBSRELA, Fabhalta, LUPKYNIS, VELPHORO, FARXIGA.
Industry payments across FL — which companies pay providers there.
